Evolving role of bivalirudin in percutaneous coronary interventions; impact of the REPLACE-2 study

Author： Salam Amar M  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.6, 2003-06, pp. : 1027-1033

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bivalirudin to replace heparin in coronary interventions?

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Can bivalirudin and provisional GP IIb/IIIa blockade REPLACE heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention?

By Doggrell Sheila  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1431-1433

Informa Healthcare

Access to resources Recommend Favorite

Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions

By White Harvey D   Chew Derek P  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Use of Prolonged Bivalirudin Infusions Following Percutaneous Coronary Intervention

By Moser Lynette  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 3, 2011-06 ,pp. : 267-276

Springer Publishing Company

Access to resources Recommend Favorite

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D.   Keating Gillian M.   Wellington Keri  

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite